Prescription pattern and appropriateness of non- steroidal anti- inflammatory drug therapy in patients with osteoarthritis- a cross sectional study.
DOI:
https://doi.org/10.37506/rrwqm041Keywords:
NSAIDs, Prescription pattern, AppropriatenessAbstract
Objectives: Current medical management of osteoarthritis (OA) is mostly palliative with non-steroidal anti-inflammatory drugs (NSAIDs) being the mainstay of therapy. NSAIDs are commonly used despite well-known side effect which may lead to various adverse drug reactions and drug toxicity. Therefore, the objectives of the study are to analyse the prescription pattern of NSAIDs in OA patients and to assess appropriateness of the use of NSAIDs in relation to gastrointestinal and cardiovascular risk.
Methods: A cross sectional study was carried out among patients attending orthopaedics out- patient department & provisionally diagnosed as OA. Patients who were prescribed any of the following drugs or their combinations were included in the study: NSAIDs, Glucocorticoids, Opioid analgesics and Symptomatic Slow Acting Drugs for OA (SYSADOA). To assess prescription pattern, ‘WHO core prescribing indicators’ were used Analysis of appropriateness of NSAIDs use by the prescribers in relation to GI & CV risks, the recommendations of the ‘First International Working Party Report on Management of Patients on NSAIDs’ were adopted and categorised as appropriate or inappropriate or uncertain. Data were entered in statistical software ‘EpiInfo’. Data were represented by suitable tables & figures and expressed in frequency and percentage.
Results: A total 600 OA patients were included in the study. Out of 600 prescriptions, NSAIDs were prescribed in 547 prescriptions (91.17%). Total 402 prescriptions were analyzed for appropriateness of NSAIDs therapy. Out of total 402 prescriptions, 222 (55.23%) prescriptions were found appropriate, 127 (31.59%) inappropriate and 53 (13.18%) were found as uncertain.
Conclusions: The study showed that NSAIDs should be selected more judiciously for OA patients in relation to GI and CV risk in order to reduce untoward adverse effects of these agents.
Key-words: NSAIDs, Prescription pattern, Appropriateness.
References
Azad CS, Singh AK, Pandey P, Singh M, Chaudhary P, Tia N. Osteoarthritis in India: An Epidemiological Aspect. Int J of Recent Scientific Res 2017; 8(10): 20918-22.
Garg Y, Singh J, Sohal HS, Gore R, and Kumar A. Comparison of clinical effectiveness and safety of newer nonsteroidal anti-inflammatory drugs in patients of osteoarthritis of knee joints: A randomised, prospective, open label parallel group study. Indian J Pharmacol 2017; 49(5):383-9.
Paul AD, Chauhan CK. Study of usage pattern of nonsteroidal anti-inflammatory drugs (NSAIDs) among different practise categories in Indian clinical setting. Eur J Clin Pharmacol 2005; 60:889-92.
WHO: The Rational Use of Drugs. Report of a Conference of Experts, Nairobi, 25 -29 November 1985.Geneva: World Health Organization; 1987.
Lanas A, Garcia-Tell G, Armada B, and Alvaro AO: Prescription patterns and appropriateness of NSAID therapy to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis. BMC Medicine 2011; 9(38):1-7.
WHO: How to Investigate Drug use in Health Facilities: Selected Drug Use Indicators. WHO/DAP/93.1.Geneva: WHO; 1993.
Vaishnavi P.R.R, Gaikwad N, Dhaneria SP: Assessment of nonsteroidal anti-inflammatory drug use pattern using WHO indicators: A cross sectional study in a tertiary care teaching hospital of Chhattisgarh. Indian J Pharmacol 2017; 49(6): 445-50.
Tannenbaum H, Peloso PM, Russell AS, Marlow B. An evidence-based approach to prescribing NSAIDs in the treatment of Osteoarthritis and rheumatoid arthritis: the Second Canadian Consensus Conference. Can J Clin Pharmacol 2000; (supplA):4A-16A.
Hallas J, Lauritsen J, Villadsen HD. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high risk groups by excess risk estimates. Scand J Gastroenterol 1995; 30:438-44.
Hippisley –Cox J, Coupland C, Logan R. Risk of adverse gastrointestinal outcomes in patients taking cyclo oxygenase 2 inhibitors or conventional non-steroidal anti-inflammatory drugs: Population based nested case control analysis. BMJ 2005; 331(7528):1310-16.
Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet1994; 343:769-72.
Laine L, Bombardier C, Hawkey CJ. Stratifying the risk of NSAID related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 2002; 123(4):1006-12.
Gabriel SE, Jaakkimainen L, Bombardier C. Risks for serious gastrointestinal complications related to the use of non-steroidal anti-inflammatory drugs: A meta-analysis. Ann Intern Med 1991; 115:787-96.
Piper JM, Ray WA, Daugherty JR. Corticosteroid use and peptic ulcer disease: Role of non-steroidal anti-inflammatory drugs. Ann Intern Med 1991; 114:735-40.
Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005; 353:2373-83.
National Cholesterol Education Program: Third report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). Risk assessment tool for estimating 10-year risk of developing hard CHD (myocardial infarction and coronary death). Available at http://hin.nhlbi.nih.gov/atpiii/calculator.asp?usertype=prof. Accessed December 8, 2018.
Framingham Coronary Heart Disease Risk Score to estimate risk of heart attack in 10 years. Available at: http://www.mdcalc.com/framingham-coronary-heart-disease-risk-score.
Chan FKL, Abraham NS, Scheiman JM, Laine L: Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Antiplatelet Agents. Am J Gastroenterol 2008; 103: 2908-18.
Ullal D S , Narendranath S, Kamath K R, Pai S M , Kamath U S , Savur AD. Prescribing Pattern for Osteoarthritis in a Tertiary Care Hospital. J Clinical and Diagnostic Research 2010; 4(3):2421-6.
Gupta R, Malhotra A, Malhotra P. Study of prescription pattern of drugs used in the treatment of osteoarthritis in a tertiary care teaching hospital: An observational study. IJRMS 2018; 6(3):985-9.
Isah AO, Ross – Degnan D, Quick J, Laing R, Mabadeje AF. The Development of Standard Values for the WHO Drug use Prescribing Indicators.ICUM/EDM/WHO.Availablefrom:http://www.archives.who.int/prduc2004/rducd/ICIUM_Posters /1a2_txt.htm.[ last accessed on 2020 March 20].
Jadhav M P, Dominic J C, Mukte A P. A prospective observational study to assess quality of life and prescription pattern in osteoarthritis patients at a tertiary care health center in Mumbai. Indian J Med Sci 2011; 65:58-63.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Debasree Bhaumik, Lakshman Das, Prithul Bhattacharjee, Ranjib Ghosh, Abhijit Sarkar, Paramita Chakraborti, Swagata Datta
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en